Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01171482
Recruitment Status : Terminated (There were problems with national reimbursement policies.)
First Posted : July 28, 2010
Last Update Posted : April 26, 2017
Information provided by (Responsible Party):
Jung-Hwan Yoon, Seoul National University Hospital

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 2016
  Actual Study Completion Date : April 2016